The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
Treating inflammation by blocking interleukin-1 in humans
Open accessAbstract
IL-1 is a master cytokine of local and systemic inflammation. With the availability of specific IL-1 targeting therapies, a broadening list of diseases has revealed the pathologic role of IL-1-mediated inflammation. Although IL-1, either IL-1α or IL-1β, was administered to patients in order to improve bone marrow function or increase host immune responses to cancer, these patients experienced unacceptable toxicity with fever, anorexia, myalgias, arthralgias, fatigue, gastrointestinal upset and sleep disturbances; frank hypotension occurred. Thus it was not unexpected that specific pharmacological blockade of IL-1 activity in inflammatory diseases would be beneficial. Monotherapy blocking IL-1 activity in a broad spectrum of inflammatory syndromes results in a rapid and sustained reduction in disease severity. In common conditions such as heart failure and gout arthritis, IL-1 blockade can be effective therapy. Three IL-1blockers have been approved: the IL-1 receptor antagonist, anakinra, blocks the IL-1 receptor and therefore reduces the activity of IL-1α and IL-1β. A soluble decoy receptor, rilonacept, and a neutralizing monoclonal anti-interleukin-1β antibody, canakinumab, are also approved. A monoclonal antibody directed against the IL-1 receptor and a neutralizing anti-IL-1α are in clinical trials. By specifically blocking IL-1, we have learned a great deal about the role of this cytokine in inflammation but equally important, reducing IL-1 activity has lifted the burden of disease for many patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Self-citationNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,408
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Anti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
Self-citationRituximab, B-lymphocyte depletion, and preservation of beta-cell function
Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H., Becker, D. J., Gitelman, S. E., Goland, R., Gottlieb, P. A., Marks, J. B., McGee, P. F., Moran, A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904452 · Cited by 1,093
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,065
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R., Tedgård, U., Cowen, E. W., Pham, T.-H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 987
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930
Pascual, V., Allantaz, F., Arce, E., Punaro, M., & Banchereau, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050473 · Cited by 922
Chen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner, J. B., Leslie, K. S., Hachulla, E., Quartier, P., Gitton, X., Widmer, A., Patel, N., & Hawkins, P. N. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810787 · Cited by 869
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
Hawkins, P. N., Lachmann, H. J., Aganna, E., & McDermott, M. F. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20033 · Cited by 744
A pilot study of IL-1 inhibition by anakinra in acute gout
So, A., De Smedt, T., Revaz, S., & Tschopp, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2143 · Cited by 727
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Ruperto, N., Brunner, H. I., Quartier, P., Constantin, T., Wulffraat, N., Horneff, G., Brik, R., McCann, L., Kasapcopur, O., Rutkowska-Sak, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205099 · Cited by 713
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
Self-citationInterleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
Hawkins, P. N., Lachmann, H. J., & McDermott, M. F. (2003) · New England Journal of Medicine · doi:10.1056/nejm200306193482523 · Cited by 654
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Quartier, P., Allantaz, F., Cimaz, R., Pillet, P., Messiaen, C., Bardin, C., Bossuyt, X., Boutten, A., Bienvenu, J., Duquesne, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.134254 · Cited by 558
Chae, J. J., Wood, G., Masters, S. L., Richard, K., Park, G., Smith, B. J., & Kastner, D. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602081103 · Cited by 554
Hoffman, H. M., Rosengren, S., Boyle, D. L., Cho, J. Y., Nayar, J., Mueller, J. L., Anderson, J. P., Wanderer, A. A., & Firestein, G. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17401-1 · Cited by 552
Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., Lonnemann, G., Cannon, J. G., & Libby, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1902 · Cited by 537
Self-citationMohan, V. P., Scanga, C. A., Yu, K., Scott, H. M., Tanaka, K. E., Tsang, E., Tsai, M. C., Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1847-1855.2001 · Cited by 536
Chevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, D., Kivitz, A. J., Silver, D., & Appleton, B. E. (2009) · Arthritis Care & Research · doi:10.1002/art.24096 · Cited by 533
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Solovic, I., Sester, M., Gomez-Reino, J. J., Rieder, H. L., Ehlers, S., Milburn, H. J., Kampmann, B., Hellmich, B., Groves, R., Schreiber, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00028510 · Cited by 527
IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R., Dinarello, C. A., & Apte, R. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102048 · Cited by 522
Self-citationShoham, N. G., Centola, M., Mansfield, E., Hull, K. M., Wood, G., Wise, C. A., & Kastner, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135380100 · Cited by 493
Role of IL-1α and IL-1β in Ischemic Brain Damage
Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y., & Rothwell, N. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05528.2001 · Cited by 477
van der Zee, H. H., de Ruiter, L., van den Broecke, D. G., Dik, W. A., Laman, J. D., & Prens, E. P. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10254.x · Cited by 472
Nigrovic, P. A., Mannion, M., Prince, F. H. M., Zeft, A., Rabinovich, C. E., van Rossum, M. A. J., Cortis, E., Pardeo, M., Miettunen, P. M., Janow, G., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30128 · Cited by 463
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
Emsley, H. C. A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054882 · Cited by 445
Inflammatory markers and the risk of Alzheimer disease: The Framingham Study
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000263217.36439.da · Cited by 440
Self-citationTumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function
Cain, B. S., Meldrum, D. R., Dinarello, C. A., Meng, X., Joo, K. S., Banerjee, A., & Harken, A. H. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00018 · Cited by 421
Self-citationAn Autoinflammatory Disease Due to Homozygous Deletion of the IL1RN Locus
Reddy, S., Jia, S., Geoffrey, R., Lorier, R., Suchi, M., Broeckel, U., Hessner, M. J., & Verbsky, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809568 · Cited by 411
Lequerré, T., Quartier, P., Rosellini, D., Alaoui, F., De Bandt, M., Mejjad, O., Kone-Paut, I., Michel, M., Dernis, E., Khellaf, M., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076034 · Cited by 406
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009) · Diabetes Care · doi:10.2337/dc09-0533 · Cited by 401
Jiang, Y., Genant, H. K., Watt, I., Cobby, M., Bresnihan, B., Aitchison, R., & McCabe, D. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1001::aid-anr7>3.0.co;2-p · Cited by 399
Abbate, A., Van Tassell, B. W., Biondi-Zoccai, G., Kontos, M. C., Grizzard, J. D., Spillman, D. W., Oddi, C., Roberts, C. S., Melchior, R. D., Mueller, G. H., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.287 · Cited by 393
Self-citationFleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G., Tesser, J., Modafferi, D., Poulakos, J., & Sun, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10870 · Cited by 392
Update on gout: new therapeutic strategies and options
Terkeltaub, R. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.236 · Cited by 387
Ravelli, A., Grom, A. A., Behrens, E. M., & Cron, R. Q. (2012) · Genes & Immunity · doi:10.1038/gene.2012.3 · Cited by 386
Gattorno, M., Piccini, A., Lasigliè, D., Tassi, S., Brisca, G., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M. A., Caroli, F., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23437 · Cited by 382
Abbate, A., Salloum, F. N., Vecile, E., Das, A., Hoke, N. N., Straino, S., Biondi-Zoccai, G. G. L., Houser, J.-E., Qureshi, I. Z., Ownby, E. D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.740233 · Cited by 360
Schlesinger, N., Alten, R. E., Bardin, T., Schumacher, H. R., Bloch, M., Gimona, A., Krammer, G., Murphy, V., Richard, D., & So, A. K. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200908 · Cited by 359
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system
Hess, A., Axmann, R., Rech, J., Finzel, S., Heindl, C., Kreitz, S., Sergeeva, M., Saake, M., Garcia, M., Kollias, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011774108 · Cited by 356
Moran, A., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Greenbaum, C. J., Herold, K. C., Marks, J. B., Raskin, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60023-9 · Cited by 356
Rapid responses to anakinra in patients with refractory adult‐onset Still's disease
Fitzgerald, A. A., LeClercq, S. A., Yan, A., Homik, J. E., & Dinarello, C. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21061 · Cited by 350
Self-citationAnakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Cohen, I., Rider, P., Carmi, Y., Braiman, A., Dotan, S., White, M. R., Voronov, E., Martin, M. U., Dinarello, C. A., & Apte, R. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915018107 · Cited by 329
Self-citationJoosten, L. A. B., Netea, M. G., Mylona, E., Koenders, M. I., Malireddi, R. K. S., Oosting, M., Stienstra, R., van de Veerdonk, F. L., Stalenhoef, A. F., Giamarellos‐Bourboulis, E. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27667 · Cited by 328
Self-citationThe role of microparticles in the pathogenesis of rheumatic diseases
Beyer, C., & Pisetsky, D. S. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.229 · Cited by 324
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Meissner, F., Molawi, K., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002396107 · Cited by 318
Braun‐Falco, M., Kovnerystyy, O., Lohse, P., & Ruzicka, T. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.025 · Cited by 318
So, A., De Meulemeester, M., Pikhlak, A., Yücel, A. E., Richard, D., Murphy, V., Arulmani, U., Sallstig, P., & Schlesinger, N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27600 · Cited by 315
Gattorno, M., Pelagatti, M. A., Meini, A., Obici, L., Barcellona, R., Federici, S., Buoncompagni, A., Plebani, A., Merlini, G., & Martini, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23475 · Cited by 312
In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
Lachmann, H. J., Lowe, P., Felix, S. D., Rordorf, C., Leslie, K., Madhoo, S., Wittkowski, H., Bek, S., Hartmann, N., Bosset, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082481 · Cited by 312
Pomerantz, B. J., Reznikov, L. L., Harken, A. H., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041611398 · Cited by 310
Self-citationIkonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., & Kremastinos, D. T. (2008) · Circulation · doi:10.1161/circulationaha.107.731877 · Cited by 307
Cohen, S. B., Moreland, L. W., Cush, J. J., Greenwald, M. W., Block, S., Shergy, W. J., Hanrahan, P. S., Kraishi, M. M., Patel, A., Sun, G., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016014 · Cited by 305
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
Fleischmann, R. M., Tesser, J., Schiff, M. H., Schechtman, J., Burmester, G.-R., Bennett, R., Modafferi, D., Zhou, L., Bell, D., & Appleton, B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048371 · Cited by 305
Terkeltaub, R., Sundy, J. S., Schumacher, H. R., Murphy, F., Bookbinder, S., Biedermann, S., Wu, R., Mellis, S., & Radin, A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108936 · Cited by 300
Joosten, L. A. B., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M. A., Sparrer, H., Pham, C. T., van der Meer, J. W. M., Dinarello, C. A., & van den Berg, W. B. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25006 · Cited by 296
Self-citationStojanov, S., Lapidus, S., Chitkara, P., Feder, H., Salazar, J. C., Fleisher, T. A., Brown, M. R., Edwards, K. M., Ward, M. M., Colbert, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103681108 · Cited by 294
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Self-citationSchnitzler's syndrome: diagnosis, treatment, and follow‐up
Simon, A., Asli, B., Braun‐Falco, M., De Koning, H., Fermand, J. ‐., Grattan, C., Krause, K., Lachmann, H., Lenormand, C., Martinez‐Taboada, V., et al. (2013) · Allergy · doi:10.1111/all.12129 · Cited by 282
Van Tassell, B. W., Arena, R., Biondi-Zoccai, G., McNair Canada, J., Oddi, C., Abouzaki, N. A., Jahangiri, A., Falcao, R. A., Kontos, M. C., Shah, K. B., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.047 · Cited by 281
Self-citationNeven, B., Marvillet, I., Terrada, C., Ferster, A., Boddaert, N., Couloignier, V., Pinto, G., Pagnier, A., Bodemer, C., Bodaghi, B., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25057 · Cited by 265
Gattorno, M., Tassi, S., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M. A., D'Osualdo, A., Buoncompagni, A., Alpigiani, M. G., Alessio, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22842 · Cited by 247
Lust, J. A., Lacy, M. Q., Zeldenrust, S. R., Dispenzieri, A., Gertz, M. A., Witzig, T. E., Kumar, S., Hayman, S. R., Russell, S. J., Buadi, F. K., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.2.114 · Cited by 246
Cohen, S. B., Proudman, S., Kivitz, A. J., Burch, F. X., Donohue, J. P., Burstein, D., Sun, Y.-N., Banfield, C., Vincent, M. S., Ni, L., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3430 · Cited by 246
Schlesinger, N., Mysler, E., Lin, H.-Y., De Meulemeester, M., Rovensky, J., Arulmani, U., Balfour, A., Krammer, G., Sallstig, P., & So, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144063 · Cited by 244
TNFRSF1A mutations and autoinflammatory syndromes
Galon, J., Aksentijevich, I., McDermott, M. F., O’Shea, J. J., & Kastner, D. L. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00124-2 · Cited by 243
Aróstegui, J. I., Arnal, C., Merino, R., Modesto, C., Antonia Carballo, M., Moreno, P., García‐Consuegra, J., Naranjo, A., Ramos, E., de Paz, P., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22966 · Cited by 238
Consensus treatment plans for new‐onset systemic juvenile idiopathic arthritis
Dewitt, E. M., Kimura, Y., Beukelman, T., Nigrovic, P. A., Onel, K., Prahalad, S., Schneider, R., Stoll, M. L., Angeles‐Han, S., Milojevic, D., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21625 · Cited by 238
Blockade of interleukin 1 in type 1 diabetes mellitus
Mandrup-Poulsen, T., Pickersgill, L., & Donath, M. Y. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.271 · Cited by 237
Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1α
Berda-Haddad, Y., Robert, S., Salers, P., Zekraoui, L., Farnarier, C., Dinarello, C. A., Dignat-George, F., & Kaplanski, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116848108 · Cited by 232
Self-citationVan Tassell, B. W., Arena, R. A., Toldo, S., Mezzaroma, E., Azam, T., Seropian, I. M., Shah, K., Canada, J., Voelkel, N. F., Dinarello, C. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033438 · Cited by 232
Self-citationGoldbach‐Mansky, R., Shroff, S. D., Wilson, M., Snyder, C., Plehn, S., Barham, B., Pham, T., Pucino, F., Wesley, R. A., Papadopoulos, J. H., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23620 · Cited by 229
Brenner, M., Ruzicka, T., Plewig, G., Thomas, P., & Herzer, P. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09404.x · Cited by 225
Open label trial of anakinra in active ankylosing spondylitis over 24 weeks
Haibel, H., Rudwaleit, M., Listing, J., & Sieper, J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023176 · Cited by 222
Kuemmerle-Deschner, J. B., Hachulla, E., Cartwright, R., Hawkins, P. N., Tran, T. A., Bader-Meunier, B., Hoyer, J., Gattorno, M., Gul, A., Smith, J., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.152728 · Cited by 222
Sibley, C. H., Plass, N., Snow, J., Wiggs, E. A., Brewer, C. C., King, K. A., Zalewski, C., Kim, H. J., Bishop, R., Hill, S., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34409 · Cited by 220
Granowitz, E. V., Porat, R., Mier, J. W., Pribble, J. P., Stiles, D. M., Bloedow, D. C., Catalano, M. A., Wolff, S. M., & Dinarello, C. A. (1992) · Cytokine · doi:10.1016/1043-4666(92)90078-6 · Cited by 220
Self-citationBlocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson, S. B. (2002) · Rheumatology · doi:10.1093/rheumatology/41.9.972 · Cited by 217
Meinzer, U., Quartier, P., Alexandra, J.-F., Hentgen, V., Retornaz, F., & Koné-Paut, I. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2010.11.003 · Cited by 205
Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy
Chae, J. J., Aksentijevich, I., & Kastner, D. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07733.x · Cited by 205
Efficacy of anti-IL-1 treatment in Majeed syndrome
Herlin, T., Fiirgaard, B., Bjerre, M., Kerndrup, G., Hasle, H., Bing, X., & Ferguson, P. J. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201818 · Cited by 200
Anakinra for flares of pyogenic arthritis in PAPA syndrome
Dierselhuis, M. P. (2005) · Rheumatology · doi:10.1093/rheumatology/keh479 · Cited by 200
Chevalier, X., Giraudeau, B., Conrozier, T., Marliere, J., Kiefer, P., & Goupille, P. (2005) · PubMed · Cited by 197
Ruperto, N., Quartier, P., Wulffraat, N., Woo, P., Ravelli, A., Mouy, R., Bader‐Meunier, B., Vastert, S. J., Noseda, E., D'Ambrosio, D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33342 · Cited by 196
Stack, J. H., Beaumont, K., Larsen, P. D., Straley, K. S., Henkel, G. W., Randle, J. C. R., & Hoffman, H. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2630 · Cited by 190
Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever: A Randomized Trial
Hashkes, P. J., Spalding, S. J., Giannini, E. H., Huang, B., Johnson, A., Park, G., Barron, K. S., Weisman, M. H., Pashinian, N., Reiff, A. O., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-8-201210160-00003 · Cited by 188
Leslie, K. S., Lachmann, H. J., Bruning, E., McGrath, J. A., Bybee, A., Gallimore, J. R., Roberts, P. F., Woo, P., Grattan, C. E., & Hawkins, P. N. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.12.1591 · Cited by 186
Demidowich, A. P., Freeman, A. F., Kuhns, D. B., Aksentijevich, I., Gallin, J. I., Turner, M. L., Kastner, D. L., & Holland, S. M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34332 · Cited by 184
Sloan-Lancaster, J., Abu-Raddad, E., Polzer, J., Miller, J. W., Scherer, J. C., De Gaetano, A., Berg, J. K., & Landschulz, W. H. (2013) · Diabetes Care · doi:10.2337/dc12-1835 · Cited by 184
Kuemmerle-Deschner, J. B., Tyrrell, P. N., Koetter, I., Wittkowski, H., Bialkowski, A., Tzaribachev, N., Lohse, P., Koitchev, A., Deuter, C., Foell, D., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30149 · Cited by 177
Lipsker, D. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-38 · Cited by 177
Norheim, K. B., Harboe, E., Gøransson, L. G., & Omdal, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030123 · Cited by 176
van Asseldonk, E. J. P., Stienstra, R., Koenen, T. B., Joosten, L. A. B., Netea, M. G., & Tack, C. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2992 · Cited by 173
On-demand anakinra treatment is effective in mevalonate kinase deficiency
Bodar, E. J., Kuijk, L. M., Drenth, J. P. H., van der Meer, J. W. M., Simon, A., & Frenkel, J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.149922 · Cited by 168
Self-citationPicco, P. P., Brisca, G., Traverso, F., Loy, A., Gattorno, M., & Martini, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24174 · Cited by 167
Bodar, E. J., van der Hilst, J. C. H., Drenth, J. P. H., van der Meer, J. W. M., & Simon, A. (2005) · PubMed · Cited by 166
Beneficial response to interleukin 1 receptor antagonist in traps
Simon, A., Bodar, E. J., van der Hilst, J. C. H., van der Meer, J. W. M., Fiselier, T. J. W., Cuppen, M. P. J. M., & Drenth, J. P. H. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.039 · Cited by 164
Self-citationAlten, R., Gómez-Reino, J. J., Durez, P., Beaulieu, A. D., Sebba, A. I., Krammer, G., Preiss, R., Arulmani, U., Widmer, A., Gitton, X., et al. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-153 · Cited by 161
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
Cronstein, B. N., & Sunkureddi, P. R. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31827d8790 · Cited by 160
Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes
Simon, A., & van der Meer, J. W. M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00504.2006 · Cited by 160
Circulating Dickkopf-1 Is Correlated with Bone Erosion and Inflammation in Rheumatoid Arthritis
Wang, S., Liu, Y., Ye, H., Guo, J., Li, R., Liu, X., & Li, Z. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100089 · Cited by 159
Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood
Eleftheriou, D., Gerschman, T., Sebire, N. J., Woo, P. M., Pilkington, C., & Brogan, P. A. (2010) · Rheumatology · doi:10.1093/rheumatology/keq122 · Cited by 157
Tassi, S., Carta, S., Delfino, L., Caorsi, R., Martini, A., Gattorno, M., & Rubartelli, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000779107 · Cited by 153
Rissanen, A., Howard, C. P., Botha, J., Thuren, T. Y., & for the Global Investigators (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01637.x · Cited by 153
Simonini, G., Xu, Z., Caputo, R., de Libero, C., Pagnini, I., Pascual, V., & Cimaz, R. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37776 · Cited by 152
Lovell, D. J., Bowyer, S. L., & Solinger, A. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20953 · Cited by 150
Topological Frustration and the Folding of Interleukin-1β
Gosavi, S., Chavez, L. L., Jennings, P. A., & Onuchic, J. N. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.074 · Cited by 148
A case of macrophage activation syndrome successfully treated with anakinra
Kelly, A., & Ramanan, A. V. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0919 · Cited by 147
Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra
McGonagle, D. G., Tan, A. L., Shankaranarayana, S., Madden, J. M., Emery, P., & McDermott, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.073759 · Cited by 146
Rationale and efficacy of interleukin-1 targeting in Erdheim–Chester disease
Aouba, A., Georgin‐Lavialle, S., Pagnoux, C., Silva, N. M., Renand, A., Galateau-Sallé, F., Toquin, S. L., Bensadoun, H., Larousserie, F., Silvera, S., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279240 · Cited by 144
Long‐Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Lovell, D. J., Giannini, E. H., Reiff, A. O., Kimura, Y., Li, S. C., Hashkes, P. J., Wallace, C. A., Onel, K. B., Foell, D., Wu, R., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38042 · Cited by 142
Krause, K., Weller, K., Stefaniak, R., Wittkowski, H., Altrichter, S., Siebenhaar, F., Zuberbier, T., & Maurer, M. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02843.x · Cited by 142
Brück, N., Suttorp, M., Kabus, M., Heubner, G., Gahr, M. L., & Peßler, F. (2011) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318205092d · Cited by 142
Koné‐Paut, I., Lachmann, H. J., Kuemmerle-Deschner, J. B., HACHULLA, E., Leslie, K. S., Mouy, R., Ferreira, A., Lheritier, K., Patel, N. P., Preiss, R., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3535 · Cited by 141
Marzano, A. V., Ishak, R. S., Saibeni, S., CROSTI, C., Meroni, P. L., & Cugno, M. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8351-x · Cited by 140
Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA
Goldbach‐Mansky, R. T. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0165-y · Cited by 139
Schlesinger, N., Meulemeester, M. D., Pikhlak, A., Yücel, E., Richard, D., Murphy, V., Arulmani, U., Sallstig, P., & So, A. K.-L. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3297 · Cited by 139
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome
de Koning, H. D., Bodar, E. J., Simon, A., van der Hilst, J. C. H., Netea, M. G., & van der Meer, J. W. M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045245 · Cited by 138
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Singh, J. A., Christensen, R., Wells, G. A., Suarez-Almazor, M. E., Buchbinder, R., Lopez-Olivo, M. A., Ghogomu, E. T., & Tugwell, P. (2010) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802010000500013 · Cited by 137
Kötter, I., Wacker, A., Koch, S., Henes, J. C., Richter, C., Engel, A., Günaydın, İ., & Kanz, L. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.04.002 · Cited by 136
Amparo, F., Dastjerdi, M. H., Okanobo, A., Ferrari, G., Smaga, L., Hamrah, P., Jurkunas, U. V., Schaumberg, D. A., & Dana, R. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.195 · Cited by 132
Moser, C. E., Pohl, G., Haslinger, I., Knapp, S., Rowczenio, D. M., Russel, T., Lachmann, H. J., Lang, U., & Kovarik, J. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn646 · Cited by 132
MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease
Stoffels, M., Szperl, A., Simon, A., Netea, M. G., Plantinga, T. S., van Deuren, M., Kamphuis, S., Lachmann, H. J., Cuppen, E. P. J. G., Kloosterman, W. P., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202580 · Cited by 123
Terkeltaub, R. A., Schumacher, H. R., Carter, J. D., Baraf, H. S. B., Evans, R. R., Wang, J., King-Davis, S., & Weinstein, S. P. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4159 · Cited by 122
Schumacher, H. R., Evans, R. R., Saag, K. G., Clower, J. W., Jennings, W., Weinstein, S. P., Yancopoulos, G. D., Wang, J., & Terkeltaub, R. A. (2012) · Arthritis Care & Research · doi:10.1002/acr.21690 · Cited by 121
Successful treatment of resistant pseudogout with anakinra
McGonagle, D. G., Tan, A. L., Madden, J. M., Emery, P., & McDermott, M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23119 · Cited by 121
IL-1β Receptor Antagonist Reduces Inflammation in Hemodialysis Patients
Hung, A. M., Ellis, C. D., Shintani, A., Booker, C., & Ikizler, T. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010070760 · Cited by 121
Kuemmerle-Deschner, J. B., Ramos, E., Blank, N., Roesler, J., Felix, S. D., Jung, T., Stricker, K., Chakraborty, A., Tannenbaum, S., Wright, A. M., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3266 · Cited by 121
Lepore, L., Paloni, G., Caorsi, R., Alessio, M., Rigante, D., Ruperto, N., Cattalini, M., Tommasini, A., Zulian, F., Ventura, A., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.02.040 · Cited by 120
Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
Galeotti, C., Meinzer, U., Quartier, P., et al. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes097 · Cited by 119
Kamari, Y., Werman-Venkert, R., Shaish, A., Werman, A., Harari, A., Gonen, A., Voronov, E., Grosskopf, I., Sharabi, Y., Grossman, E., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.026 · Cited by 119
Self-citationHoffman, H. M., Throne, M. L., Amar, N. J., Cartwright, R. C., Kivitz, A., Soo, Y., & Weinstein, S. P. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.09.009 · Cited by 119
Hensen, J., Howard, C. P., Walter, V., & Thuren, T. Y. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.07.003 · Cited by 115
Abbate, A., Tassell, B. W. V., Seropian, I. M., Toldo, S. A., Robati, R., Varma, A., Salloum, F. N., Smithson, L. A., & Dinarello, C. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq017 · Cited by 113
Self-citationGiampietro, C., Ridene, M., Lequerré, T., Costedoat-Chalumeau, N., Amoura, Z., Sellam, J., Sibilia, J., Bourgeois, P., Fautrel, B., & Inflammation), O. B. O. T. C. (. R. E. (2012) · Arthritis Care & Research · doi:10.1002/acr.21901 · Cited by 112
Cailliez, M., Garaix, F., Rousset‐Rouvière, C., Bruno, D., Koné‐Paut, I., Sarles, J., Chabrol, B., & Tsimaratos, M. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0408-7 · Cited by 112
de Koning, H. D., Schalkwijk, J., van der Ven‐Jongekrijg, J., Stoffels, M., van der Meer, J. W. M., & Simon, A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202192 · Cited by 111
Stankovic, K., Delmas, Y., Ureña, P., Peltier, J., Pellé, G., Jéru, I., Colombat, M., & Grateau, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr528 · Cited by 110
Hidradenitis Suppurativa and Concomitant Pyoderma Gangrenosum
Hsiao, J. L., Antaya, R. J., Berger, T. G., Maurer, T. A., Shinkai, K., & Leslie, K. S. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.328 · Cited by 106
The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis
Cohen, S. B. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.01.005 · Cited by 104
Nixon, R., Bansback, N. J., & Brennan, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem072 · Cited by 103
Laskari, K., Tzioufas, A. G., & Moutsopoulos, H. Μ. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3366 · Cited by 102
Mitha, E., Schumacher, H. R., Fouche, L. F., Luo, S., Weinstein, S. P., Yancopoulos, G. D., Wang, J., King-Davis, S., & Evans, R. R. (2013) · Rheumatology · doi:10.1093/rheumatology/ket114 · Cited by 100
Pathak, S., Goldofsky, E., Vivas, E. X., Bonagura, V. R., & Vambutas, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002275 · Cited by 99
Kluger, N., Gil-Bistes, D., Guillot, B., & Bessis, D. (2011) · Dermatology · doi:10.1159/000326112 · Cited by 97
Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease
Bilginer, Y., Ayaz, N. A., & Özen, S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1279-8 · Cited by 95
Cryopyrin‐Associated Periodic Syndromes
Ahmadi, N., Brewer, C. C., Zalewski, C. K., King, K. A., Butman, J. A., Plass, N., Henderson, C., Goldbach‐Mansky, R. T., & Kim, H. J. (2011) · Otolaryngology · doi:10.1177/0194599811402296 · Cited by 93
Pericardial syndromes: an update after the ESC guidelines 2004
Seferovic, P. M., Ristić, A. D., Maksimović, R., Simeunović, D. S., Milinković, I., Mitrović, J., Kanjuh, V., Pankuweit, S., & Maisch, B. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9335-x · Cited by 91
Geusau, A., Mothes‐Luksch, N., Nahavandi, H., Pickl, W. F., Wise, C. A., Pourpak, Z., Ponweiser, E., Eckhart, L., & Sunder‐Plaßmann, R. (2013) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.717 · Cited by 89
Colina, M., Pizzirani, C., Khodeir, M., Falzoni, S., Bruschi, M., Trotta, F., & Virgilio, F. D. (2010) · Rheumatology · doi:10.1093/rheumatology/keq074 · Cited by 89
Inflammatory Role of ASC in Antigen-Induced Arthritis Is Independent of Caspase-1, NALP-3, and IPAF
Kolly, L., Karababa, M., Joosten, L. A. B., Narayan, S., Salvi, R., Pétrilli, V., Tschopp, J., van den Berg, W. B., So, A. K.-L., & Busso, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802173 · Cited by 87
Macrophage Activation Syndrome Treated with Anakinra
DURAND, M., TROYANOV, Y., LAFLAMME, P., & GREGOIRE, G. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091046 · Cited by 86
Rynne, M., Maclean, C., Bybee, A., McDermott, M. F., & Emery, P. E. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038091 · Cited by 86
THE ROLE OF INTERLEUKIN-1β IN THE PATHOGENESIS OF MULTIPLE MYELOMA
Lust, J. A., & Donovan, K. A. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70115-5 · Cited by 85
IL-1 regulates in vivo C–X–C chemokine induction and neutrophil sequestration following endotoxemia
Calkins, C. M., Bensard, D. D., Shames, B. D., Pulido, E. J., Abraham, E. H., Fernandez, N., Meng, X., Dinarello, C. A., & McIntyre, R. C. (2002) · Journal of Endotoxin Research · doi:10.1177/09680519020080010601 · Cited by 84
Self-citationAbbate, A., Tassell, B. W. V., & Biondi‐Zoccai, G. (2012) · BioDrugs · doi:10.1007/bf03261881 · Cited by 84
Cohen, S. B., Strand, V., Aguilar, D., & Ofman, J. J. (2004) · Rheumatology · doi:10.1093/rheumatology/keh152 · Cited by 84
Neurologic manifestations of the cryopyrin-associated periodic syndrome
Kitley, J., Lachmann, H. J., Pinto, A. A., & Ginsberg, L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d9ed69 · Cited by 83
Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra
Ghosh, P., Cho, M., Rawat, G., Simkin, P. A., & Gardner, G. C. (2013) · Arthritis Care & Research · doi:10.1002/acr.21989 · Cited by 80
Genetic and Molecular Basis of Inflammasome-mediated Disease
Hoffman, H. M., & Brydges, S. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.135491 · Cited by 80
Demyelinating events in rheumatoid arthritis after drug exposures
Bernatsky, S., Renoux, C., & Suissa, S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.111500 · Cited by 80
Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS)
Hoffman, H. M. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902875518 · Cited by 79
Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens
Kuemmerle-Deschner, J. B., Wittkowski, H., Tyrrell, P. N., Koetter, I., Lohse, P., Ummenhofer, K., Reess, F., Hansmann, S., Koitschev, A., Deuter, C., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4237 · Cited by 79
Erosive osteoarthritis of the hand: clinical experience with anakinra
Bacconnier, L., Jørgensen, C., & Fabre, S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094284 · Cited by 77
Sumpter, K., Adhikari, S., Grishman, E. K., & White, P. C. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00761.x · Cited by 76
Schnitzler syndrome: Treatment failure to rituximab but response to anakinra
Eiling, E., Möller, M., Kreiselmaier, I., Brasch, J., & Schwarz, T. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.03.036 · Cited by 75
Behrens, E. M., Kreiger, P. A., Cherian, S., & Cron, R. Q. (2006) · PubMed · Cited by 75
Ottaviani, S., Brunier, L., Sibilia, J., Maurier, F., Ardizzone, M., Wendling, D., Gill, G., Palazzo, É., Meyer, O., & Dieudé, P. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.07.018 · Cited by 74
Announ, N., Palmer, G., Guerne, P., & Gabay, C. (2009) · Joint Bone Spine · doi:10.1016/j.jbspin.2009.01.001 · Cited by 74
Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
Devine, E. B., Alfonso‐Cristancho, R., & Sullivan, S. D. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.1.39 · Cited by 74
Falling into TRAPS – receptor misfolding in the TNF receptor 1-associated periodic fever syndrome
Kimberley, F. C., Lobito, A. A., Siegel, R. M., & Screaton, G. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2197 · Cited by 74
Successful Treatment of Severe Hidradenitis Suppurativa With Anakinra
Zarchi, K., Dufour, D., & Jemec, G. B. E. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5377 · Cited by 73
Higher-dose Anakinra Is Effective in a Case of Medically Refractory Macrophage Activation Syndrome
Kahn, P. J., & Cron, R. Q. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121098 · Cited by 72
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
Delluc, A., Limal, N., Puéchal, X., Francès, C., Pietté, J. C., & Cacoub, P. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068254 · Cited by 69
Inhibition of IL-1β Improves Fatigue in Type 2 Diabetes
Cavelti‐Weder, C., Furrer, R., Keller, C., Babians-Brunner, A., Solinger, A. M., Gast, H., Fontana, A., Donath, M. Y., & Penner, I. (2011) · Diabetes Care · doi:10.2337/dc11-1196 · Cited by 69
Vambutas, A., DeVoti, J. A., Goldofsky, E., Gordon, M., LESSER, M. L., & Bonagura, V. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005293 · Cited by 68
Caorsi, R., Lepore, L., Zulian, F., Alessio, M., Stabile, A., Insalaco, A., Finetti, M., Battagliese, A., Martini, G., Bibalo, C., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4184 · Cited by 67
Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
Mitroulis, I., Papadopoulos, V. P., Konstantinidis, T. G., & Ritis, K. (2008) · PubMed · Cited by 66
Jung, N., Hellmann, M., Hoheisel, R., Lehmann, C., Haase, I., Perniok, A., Hallek, M. J., & RUBBERT, A. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1504-5 · Cited by 66
Failure of Anti-Interleukin-1 Therapy in Severe Hidradenitis Suppurativa: A Case Report
van der Zee, H. H., & Prens, E. P. (2013) · Dermatology · doi:10.1159/000343221 · Cited by 65
Case of anakinra as a steroid‐sparing agent for gout inflammation
Gratton, S. B., Scalapino, K. J., & Fye, K. H. (2009) · Arthritis Care & Research · doi:10.1002/art.24694 · Cited by 63
IL-1β Biological Treatment of Familial Mediterranean Fever
Soriano, A., Verrecchia, E., Afeltra, A., Landolfi, R., & Manna, R. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8358-y · Cited by 62
Kuemmerle-Deschner, J. B., Lohse, P., Koetter, I., Dannecker, G. E., Reess, F., Ummenhofer, K., Koch, S., Tzaribachev, N., Bialkowski, A., & Benseler, S. M. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3526 · Cited by 61
Cited by
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Cytokines in Inflammatory Disease
Kany, S., Vollrath, J. T., & Relja, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236008 · Cited by 1,971
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
Self-citationChamorro, Á., Dirnagl, U., Urra, X., & Planas, A. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00114-9 · Cited by 1,198
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Jiang, H., He, H., Chen, Y., Huang, W., Cheng, J., Ye, J., Wang, A., Tao, J., Wang, C., Liu, Q., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171419 · Cited by 748
Metadata
- Authors
- Dinarello, C. A., & van der Meer, J. W. M.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 25
- Issue
- 6
- Pages
- 469-484
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2124335748
- Cited by
- 549
- References
- 258
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.